Taxiarchis Kourelis, MD | oneAMYLOIDOSISvoice

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Taxiarchis Kourelis, MD

Healthcare Professional
Division of Hematology
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States

Dr. Taxiarchis Kourelis is a hematology specialist in Mayo Clinic, Rochester, Minnesota and has been practicing for 7 years. He is a specialist in hematology, oncology, and medical oncology. 

Dr. Kourelis has received board certifications in hematology, internal medicine and medical oncology. He completed his residency from the University of Connecticut and MD from the University of Athens Medical School.

Dr. Kourelis has special interests in multiple myeloma, light chain amyloidosis, POEMS syndrome and monoclonal immunoglobulin deposition disease. He has received an advanced fellowship in myeloma, amyloid, and dysproteinemia disorders from division of hematology.


Representative Publications:

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma 

Natural history of multiple myeloma with de novo del(17p) 

Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis 

Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response 

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.